Tollovir

N/A

Report date: 2021/12/07 09:52:36

Base Information

Drug NameTollovir
Drug Alias NameTollovir
ClassificationNatural product/Extract
Mechanisms of ActionSARS-CoV-2-3C-like-proteinase inhibitorsCytokines inhibitors
TargetsSARS-CoV-2-3C-like-proteinaseCytokines
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTodos Medical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTodos Medical Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A